Impact of PD1-lymphocytes in Bronchoalveolar Lavage of Patients With Lung Cancer

Multinational Observational Study to Describe Diagnostic Stage Shift in Patients With Lung Cancer Using Medical Records

NCT06842056 ·Status: NOT_YET_RECRUITING

Sensitivity of PDL-1-analysis From Pleural Effusion in Non-small Cell Lung Cancer

NCT02855281 ·Status: COMPLETED

PDL-1 Expression on Circulating Tumor Cells in Non-small Cell Lung Cancer

NCT02827344 ·Status: COMPLETED

Evaluation of PD1 / PDL1 Expression on Blood Cells & Tumor Tissue, Their Role as a Prognostic Target in NSCLC Patients

NCT02758314 ·Status: UNKNOWN

Biomarkers for Early Detection of Lung Cancer in Patients With Lung Cancer, Participants at High-Risk for Developing Lung Cancer, or Healthy Volunteers

NCT00899262 ·Status: UNKNOWN

The Impact of Polynuclear Neutrophils' Intra-tumoral Rate and the Mutational Status in Pulmonary Adenocarcinomas on Survival

NCT04761640 ·Status: UNKNOWN

Lung Cancer Screening Using DNA Methylation Changes in Circulated Tumor and PBMC DNA

NCT03499678 ·Status: TERMINATED

Retrospective Observational Study on Prediction of Response to PD-1 Immunotherapy in Patients with NSCLC

NCT04886401 ·Status: RECRUITING

A Non Interventional Pilot Study on Machine Learning for ILD Detection Based on the Patient Data From Digital Devices in Unresectable Stage III Non-Small Cell Lung Cancer Patients Receiving Durvalumab

NCT04884269 ·Status: COMPLETED

Efficiency of Diagnostic Strategy for Fast Track Lung Cancer Diagnosis

NCT01779726 ·Status: COMPLETED ·Phase: NA

Optical Coherence Tomography of the Airway for Lung Cancer or Lung Disease

NCT00733252 ·Status: WITHDRAWN

The Utility of Circulating Tumor Cells as Confirmation of Pathologic Diagnosis in Patients With Suspected Early Stage Non-small Cell Lung Cancer

NCT02380196 ·Status: COMPLETED

Asia PDL1 Study Among NSCLC Patients

NCT03037086 ·Status: COMPLETED

Study of Anti-telomerase T CD4 Immunity in Metastatic Lung Cancer

NCT02846103 ·Status: COMPLETED ·Phase: NA

A Study to Assess Programmed Death Ligand-1 (PD-L1) Expression in Cytological Versus Histological Lung Cancer Specimens

NCT03092739 ·Status: COMPLETED

Immune Checkpoint Inhibitors in Advanced Non-small Cell Lung Cancer and Discovery of New Biomarkers

NCT03658460 ·Status: COMPLETED

Studies Examining the Importance of Smoking After Being Diagnosed With Lung Cancer

NCT01192256 ·Status: COMPLETED

PD-L1 Expression in Lung Cancer

NCT04992715 ·Status: UNKNOWN ·Phase: PHASE2

Epidemiologic Multicenter Prospective Study in Advanced NSCLC (Non Small Cell Lung Cancer) Patients With PDL1 (Protein Death Ligand 1) Expression.

NCT02785562 ·Status: COMPLETED ·Phase: NA

The Role of Interventional Pulmonology, Microbiota and Immune Response in the Patient With Lung Cancer

NCT05164445 ·Status: COMPLETED ·Phase: NA

Assessment of Early-detection Based on Liquid Biopsy in Lung Cancer (ASCEND-LUNG)

NCT04817046 ·Status: UNKNOWN

Study of Early Cancer Biomarkers in Breath Condensate in Population of Individuals With High-Risk of Lung Cancer Undergoing LDCT Screening.

NCT06016569 ·Status: RECRUITING ·Phase: NA

Tumor Molecular Profiling in Early Phase Clinical Trials

NCT04510766 ·Status: RECRUITING

Immune-Marker Platform for Patients With Advanced Lung Cancer

NCT07150598 ·Status: NOT_YET_RECRUITING

Sentinel Lymph Node Mapping in Detecting Cancer That Has Spread to Lymph Nodes in Patients With Non-Small Cell Lung Cancer

NCT00089310 ·Status: COMPLETED ·Phase: NA